Facebook Pixel Maharashtra, powerhouse of Indian pharma industry | Chronicle Pharmabiz - health - Bu hikayeyi Magzter.com'da okuyun

Denemek ALTIN - Özgür

Maharashtra, powerhouse of Indian pharma industry

Chronicle Pharmabiz

|

September 18, 2025

MAHARASHTRA, particularly the Mumbai-Pune corridor, is indisputably the powerhouse of the Indian pharmaceutical industry.

- Namdeo Shinde

Contributing approximately 25-30 per cent of India's total pharmaceutical output and housing over 40 per cent of the nation's pharmaceutical R&D centres, the state is a critical hub for manufacturing, innovation, and exports. However, this preeminent position is challenged by intense domestic competition, infrastructural bottlenecks, environmental concerns, and a rapidly evolving global regulatory landscape.

Region-wise distribution of pharma industry

The pharmaceutical industry in Maharashtra is strategically concentrated in key regional clusters, each with a distinct role. The Mumbai Metropolitan Region (MMR), encompassing Mumbai, Thane, Navi Mumbai, and Palghar, remains the historical and corporate heartland.

It hosts the headquarters of industry giants like Cipla, Sun Pharma, and multinational corporations such as Pfizer and GSK, serving as a central hub for corporate functions, regulatory affairs, marketing, and R&D. While still a dominant centre for formulating complex drugs and vaccines, its high operational costs and space constraints are gradually shifting manufacturing focus to other regions.

According to the Maharashtra Industrial Development Corporation (MIDC), the Mumbai and Konkan region continues to account for a significant, though dynamically changing, portion of the state's pharmaceutical units.

In contrast, Pune has solidified its status as the emerging "Pharma & Biotech Capital" of India. The region, including Pune city, Pimpri-Chinchwad, and Hinjawadi, is an epicentre of innovation, hosting a dense cluster of R&D centres, CRAMS players, and biotech startups, bolstered by world-class institutions like the National Chemical Laboratory and the Serum Institute of India. A report by the India Brand Equity Foundation (IBEF) highlights its prominence, noting over 800 manufacturing units in the broader region.

Chronicle Pharmabiz'den DAHA FAZLA HİKAYE

Chronicle Pharmabiz

FOPE urges Petroleum Min to prioritise LPG supply to pharma sector

THE Federation of Pharma Entrepreneurs (FOPE) is now concerned about the shortage of LPG (Liquefied Petroleum Gas) following the looming uncertainty with the ongoing war in West Asia.

time to read

1 mins

March 19, 2026

Chronicle Pharmabiz

BDCDA informs FDA about challenges to implement geo-tagging

THE Bangalore District Chemists and Druggists Association (BDCDA) has apprised the Karnataka FDA about the practical challenges in implementing the FDA's geo-tagging application.

time to read

1 mins

March 19, 2026

Chronicle Pharmabiz

₹1,000 cr MedTech Fund signals shift toward domestic mfg

THE Indian medical technology sector is poised for a major transformation with the launch of MedArtha Capital, the nation’s first dedicated Rs.1,000 crore growth fund focused exclusively on medtech.

time to read

1 mins

March 19, 2026

Chronicle Pharmabiz

Pharma exports to GCC countries affected by US-Israel-Iran conflict: Experts

PHARMA exports to the Gulf Cooperation Council (GCC) countries like UAE, Saudi Arabia and West Asia-North Africa (WANA) region have been badly affected due to the USIsrael-Iran conflict.

time to read

2 mins

March 19, 2026

Chronicle Pharmabiz

SEPC, AHPI hold program for wellness centres & MVTF

THE Services Export Promotion Council (SEPC) India and the Association of Healthcare Providers (AHPI) India successfully held its first meeting recently on creating an accreditation programme for Wellness Centers and Medical Value Travel Facilitators (MVTF).

time to read

1 mins

March 19, 2026

Chronicle Pharmabiz

DGFT launches risk sharing support to boost exports

IN a strategic move to expand India's global export footprint, the DGFT has introduced a new intervention under the Export Promotion Mission (EPM) aimed at strengthening export financing and improving trade access to under-served markets.

time to read

1 min

March 19, 2026

Chronicle Pharmabiz

'Need to transition from awareness reporting to performance-oriented PV'

THERE is a need to transition from awareness-driven reporting to a performance-oriented pharmacovigilance (PV) framework with measurable outcomes, said Dr V Kalaiselvan, secretary-cum-scientific director, the Indian Pharmacopoeia Commission (IPC) at the 1st Annual Meeting of Regional Centres participating in the Pharmacovigilance Programme of India (PvPI) and the Materiovigilance Programme of India (MvPI).

time to read

1 mins

March 19, 2026

Chronicle Pharmabiz

India's drug quality surveillance hits new highs

THE Central Drugs Standard Control Organisation (CDSCO) has released a comprehensive report detailing the quality surveillance of pharmaceuticals across India over the last five fiscal years.

time to read

2 mins

March 19, 2026

Chronicle Pharmabiz

Pharma Quality Excellence Awards 2026 in Mumbai

In an era of heightened regulatory scrutiny, global supply chain complexity, and accelerated innovation, compliance alone is no longer sufficient.

time to read

1 min

March 19, 2026

Chronicle Pharmabiz

Healthcare workforce eyes AI dominance via digital upskilling

INDIA'S healthcare workforce, armed with digital upskilling, is poised for AI dominance, but there are certain creases in the system that need to be ironed out for more efficient integration.

time to read

1 min

March 19, 2026

Listen

Translate

Share

-
+

Change font size